Category: CovidienSyndicate content

Stryker may bid for Smith & Nephew following 6-month no-bid period | The week in medtech M&A

November 26, 2014 by MassDevice

Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Will Stryker bid on Smith & Nephew this week?: J&J demands $7.2 billion from Boston Scientific as trial begins; Will Orange County's medtech scene lose its juice without Allergan?; BD-CareFusion deal passes US anti-trust waiting period; Sources: Stryker weighs bid for Smith & Nephew

Will Stryker bid on Smith & Nephew this week?

November 24, 2014 by Brad Perriello

HHS hits Covidien with subpoena over peripheral devices

November 24, 2014 by Brad Perriello

Covidien says it received a subpoena from the inspector general of the U.S. Health & Human Services Dept. over some of its peripheral vascular devices.

HHS grills Covidien over peripheral devices

Covidien wins FDA nod for Fortrex PTA balloon catheter

November 24, 2014 by Brad Perriello

Covidien says it won 510(k) clearance from the FDA for its Fortrex PTA balloon catheter, designed both for maintaining blood vessel access for hemodialysis and for treating peripheral artery disease.

Covidien wins FDA nod for Fortrex PTA balloon catheter

Will Stryker bid on Smith & Nephew this week?

November 24, 2014 by Brad Perriello

Speculation mounts again about a possible Stryker offer for Smith & Nephew now that a 6-month no-bid period has ended.

Will Stryker bid on Smith & Nephew this week?

UPDATED Nov. 24 with analysis from Morgan Stanley.

Covidien wins home-use CE Mark for Nellcor oxygen monitor

November 21, 2014 by Val Kennedy

Covidien says it won CE Mark approval in the European Union for home use of its Nellcor bedside SpO2 patient monitoring system.

Covidien wins CE Mark for Nellcor oxygen monitor

Covidien (NYSE:COV) said it won CE Mark approval in the European Union for home use of its Nellcor bedside SpO2 patient monitoring system.

MDT prepares $10B worth of bonds to help fund its $43B acquisition of COV | The week in medtech M&A

November 19, 2014 by MassDevice

Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Report: Medtronic readies $10B bond flotation for Covidien deal; Medtech mergers stayed strong in Q3; Sources: Philips attracts private equity bids for lighting unit; Medtronic, Covidien set timetable for shareholders meetings; Report: Actavis may buy Allergan for at least $60 billion

Report: Medtronic readies $10B bond flotation for Covidien deal

November 17, 2014 by Brad Perriello

Medtronic, Covidien set timetable for shareholders meetings

November 17, 2014 by Brad Perriello

Medtronic and Covidien set the timetable for shareholder meetings to vote on their pending, $43 billion merger.

Medtronic, Covidien set timetable for shareholders meetings